CF PHARMTECH (02652) spent 997,400 Hong Kong dollars to repurchase 27,000 shares on February 24th.
Changfeng Pharmaceutical (02652) announced that on February 24, 2026, the company spent 997,400 Hong Kong dollars to repurchase 27,000 shares, at a repurchase price of 36.6-37.18 Hong Kong dollars per share.
CF PHARMTECH (02652) announced that the company repurchased 27,000 shares on February 24, 2026, at a total cost of 997,400 Hong Kong dollars. The repurchase price per share ranged from 36.6 to 37.18 Hong Kong dollars.
Related Articles
NetEase Music (09899) February 24 spent HK$14,999,800 to repurchase 93,700 shares.
C&S Paper Co., Ltd. (002511.SZ) plans to spend 60 million to 120 million yuan to implement a stock buyback.
Maoyan Entertainment (01896) announced a profitable year, with an estimated shareholder profit of approximately 540 million to 590 million yuan in 2025, representing a year-on-year growth of approximately 196.9% to 224.4%.
NetEase Music (09899) February 24 spent HK$14,999,800 to repurchase 93,700 shares.
C&S Paper Co., Ltd. (002511.SZ) plans to spend 60 million to 120 million yuan to implement a stock buyback.
Maoyan Entertainment (01896) announced a profitable year, with an estimated shareholder profit of approximately 540 million to 590 million yuan in 2025, representing a year-on-year growth of approximately 196.9% to 224.4%.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
